Gan & Lee Pharmaceuticals USA Corporation

Gan & Lee, headquartered in Tongzhou Economic Development Zone, Beijing, China, boasts state-of-the-art buildings and GMP facilities. In 2014, it established its U.S. subsidiary in New Jersey, with plans to further expand into North America, Europe, and other regions. Gan & Lee Pharmaceuticals USA Corporation is a pharmaceutical company specializing in the development, production, and commercialization of recombinant insulin analogs and injection pens, with ambitions for global expansion. Its mission is to become a world-class pharmaceutical company by providing top-quality products to improve the lives of patients worldwide. The company’s clinical development programs are exploring new chemical entities and biologics to treat diseases in cardiovascular, metabolic, oncology, and other therapeutic areas.